A 62-year-old woman is evaluated in the emergency department for progressive dyspnea, a dr… — USMLE Step 2 CK

A 62-year-old woman is evaluated in the emergency department for progressive dyspnea, a dry cough, and profound fatigue over the past $4$ months, which have acutely worsened over the last week. She also reports significant morning stiffness in her hands and wrists lasting up to $3$ hours, along with intermittent joint swelling for the past $6$ months. Her temperature is $37.4^\circ$ C ( $99.3^\circ$ F), blood pressure is $142/88$ mmHg, pulse is $96$ /min, respiratory rate is $22$ /min, and oxygen saturation is $92\%$ on room air. Examination shows bilateral boggy swelling and tenderness of the metacarpophalangeal and proximal interphalangeal joints. Lung auscultation reveals fine crackles at both lung bases. There is no jugular venous distention, $S_3$ gallop, or peripheral edema.

Laboratory studies show:
Thyroid-stimulating hormone (TSH): $1.2$ $\mu$ U/mL (Normal: $0.4-4.0$ $\mu$ U/mL)
Free thyroxine (T4): $0.6$ ng/dL (Normal: $0.9-1.7$ ng/dL)

An arterial blood gas on room air shows $pH = 7.48$ , $PaCO_2 = 30$ mmHg, $PaO_2 = 65$ mmHg, and $HCO_3^- = 22$ mEq/L.
Chest radiograph shows diffuse, fine reticular opacities predominantly in the lower lung zones without cardiomegaly or pleural effusions.

Which of the following is the most appropriate next step in the management of this patient?

A
Administration of intravenous furosemide
B
Empiric administration of intravenous vancomycin and piperacillin-tazobactam
C
Initiation of levothyroxine replacement therapy
Measurement of serum anti-cyclic citrullinated peptide antibodiesAnswer
E
Calculation of expected respiratory compensation using Winter's formula

Answer

Measurement of serum anti-cyclic citrullinated peptide antibodies

The patient's progressive dyspnea, fine bibasilar crackles, and reticular opacities on chest radiograph are highly suggestive of interstitial lung disease (ILD). In the context of symmetric polyarthritis involving the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints with prolonged morning stiffness, the most likely underlying etiology is Rheumatoid Arthritis (RA). Extra-articular manifestations of RA occur in up to 40% of patients, with ILD being a significant cause of morbidity and mortality. Measurement of anti-cyclic citrullinated peptide (anti-CCP) antibodies is highly specific for RA and is the most appropriate next step to establish the etiology of her systemic and pulmonary findings.

Step-by-Step Solution

Analyze the patient's musculoskeletal symptoms.

Symmetric polyarthritis of the MCP and PIP joints with prolonged morning stiffness.

To identify the primary systemic inflammatory disorder, which strongly points towards Rheumatoid Arthritis.

Evaluate the respiratory presentation and radiographic findings.

Progressive dyspnea, fine bibasilar crackles, hypoxia, and reticular opacities without signs of volume overload.

To recognize interstitial lung disease (ILD) as a severe extra-articular manifestation of the underlying rheumatologic condition.

Interpret the acid-base and endocrine laboratory values.

Primary respiratory alkalosis due to hypoxia; euthyroid sick syndrome (normal TSH, low T4).

To rule out primary metabolic acidosis, primary hypothyroidism, and heart failure as alternative causes of her dyspnea and fatigue.

Determine the most appropriate next step in management.

Measurement of serum anti-CCP antibodies.

To serologically confirm the diagnosis of Rheumatoid Arthritis, which will guide both joint and pulmonary disease-modifying therapy.

Key Concept

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) diagnostic evaluation.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic